欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33924 篇 当前为第 57 页 共 3393

所属行业:医药制造业

  • 561.生物医药投融资跟踪:海外呈现复苏态势,国内仍需等待

    [医药制造业] [2024-03-06]

    全球医疗健康融资额2023年同比2022年仍有一定幅度下滑,基本接近2019年水平。2023年全球生物医药融资金额为575.43亿美元,同比2022年下滑34%,与2019年融资额631.05亿美元基本接近。2023Q4融资金额小幅仍然下滑,2023Q1-2023Q3三个季度融资金额环比保持平稳。2022Q4-2023Q3 全球医疗健康季度融资金额分别为155.52、152.45、154.58、152.03亿美元,季度间环比保持平稳。2023Q4季度融资金额为116.38亿美元,同比2022Q4季度融资金额下滑25%。


    关键词:全球医疗健康融资;中国创新药融资;CDE创新药物
  • 562.新研究有助研发抗抑郁焦虑新药物

    [科学研究和技术服务业,医药制造业] [2024-03-04]

    关键词:研究研发;抗抑郁焦虑;药物
  • 563.多项政策促进罕见病药物研发

    [医药制造业] [2024-02-29]

    关键词:罕见病;药物研发;
  • 564.全球代餐市场报告(2024-2028年)

    [医药制造业] [2024-02-29]

    Meal replacement products are calorie-controlled, pre-packaged products such as bars and beverages, which can be consumed instead of a heavy meal. Meal replacement products have many nutritional benefits. Moreover, they are affordable and convenient. Initially, meal replacement products were used by the elderly population, but now they are being marketed to adults. Major brands are also carrying out several marketing activities to create more awareness about meal replacement products.

    关键词:代餐产品;热量控制;预包装产品;能量棒和饮料;代替大餐;营养价值
  • 565.全球功能性口香糖市场报告(2023-2027年)

    [食品制造业,医药制造业,农副食品加工业] [2024-02-29]

    Functional chewing gum imparts several health benefits upon consumption, unlike traditional chewing gum, which is mainly consumed as a confectionary product. The several health benefits of functional chewing gum make it highly demanded among consumers across the world.

    关键词:糖果产品消费;传统口香糖;功能性口香糖;健康益处
  • 566.全球尤因肉瘤治疗市场报告(2024-2028年)

    [医药制造业] [2024-02-29]

    Ewing's sarcoma is a cancerous tumor that arises in the bone or soft tissue. There are different types of Ewing's sarcoma; the most common type is Ewing's sarcoma of bone. Monotherapy and combination therapy are used to treat Ewing's sarcoma. Currently, monotherapy involves treatment with chemotherapeutics, whereas combination therapy involves treatment with chemotherapeutics in combination with radiation therapy.

    关键词:尤文氏肉瘤;癌性肿瘤;单一疗法;联合疗法;化疗药物;化疗药物与放射疗法;组合治疗
  • 567.全球勃起功能障碍 (ED) 药物市场报告(2024-2028年)

    [医药制造业] [2024-02-29]

    The global ED drugs market consists of drugs indicated for the treatment of ED. These drugs include oral, topical, and other formulations, available both as prescription drugs and over-the-counter (OTC) drugs. Oral drugs were the first class of drugs that were developed for the treatment of ED. They hold a major share of the market because of their relative ease of administration. Topical drugs, sublingual, injectables, and suppositories, which have recently entered the market, hold small market shares.

    关键词:全球ED药物市场;处方药;非处方药 (OTC)
  • 568.全球皮肤科激光器市场报告(2024-2028年)

    [仪器仪表制造业,计算机、通信和其他电子设备制造业,医药制造业] [2024-02-29]

    The term dermatology laser is used to describe a type of high-energy laser designed for medical procedures within the dermatology field. Dermatological lasers use a particular wavelength of light to precisely target and penetrate a particular layer of the skin. This allows for the precise treatment of a variety of skin conditions, such as improved skin appearance, the treatment of skin diseases, the removal of unwanted hair, the removal of tattoos, the reduction of wrinkles, scars, and other skin blemishes. The use of a particular type of laser depends on the intended treatment and the target area of the body.

    关键词:皮肤科激光;皮肤科领域内;医疗程序;高能激光;精确治疗;皮肤状况
  • 569.2023年度中、美创新药获批情况跟踪报告:获批药物愈发多元化,本土创新力量不断迸发

    [医药制造业] [2024-02-27]

    2023 年,国家药品监督管理局(NMPA)共批准了 85 款新药(新药统计范围为首次在国内获批的 1 类、3.1 类、5.1 类化学药品和生物制品),其中包括 62 款化学药品(占比 72.9%)以及 23 款生物制品(占比 27.1%)。与往年相比,2023 年 NMPA 批准新药数量显著上涨,为近 6 年最高。2023 年国产新药获批 29 款,相比 2022 年显著增长。


    关键词:1类新药;抗肿瘤药物;CDER 新药
  • 570.2024 ASCO GI/GU 研究动态回顾

    [医药制造业] [2024-02-27]

    2024 年 ASCO GI 和 ASCO GU 会议召开,多项成果引人注目 ASCO GI 和 ASCO GU 分别于 1 月 18 日和 1 月 25 日开幕。海外创新药中,enfortumab vedotin(EV)一线治疗 UC 表现出色,NiPi 组合再创佳绩,tiragolumab 治疗 ESCC 的 III 期研究结果积极。两大会议上有近 70 项 国产创新药的临床成果入选(不计入仅披露临床设计的项目),其中维迪西妥单抗、CT041、戈来雷塞、ASKB589 等的早期临床数据靓丽。我们继续看好国产创新药前景,基于:1)国产 ADC 数据惊艳,彰显其成为成为肿瘤治疗新基石疗法的潜力与国内药企在该领域的全球市场竞争力;2)多项国产创新药披露优秀美国临床数据,国内药企出海能力持续提升;3)国产创新药在胰腺癌等未满足需求大但满足度低的领域中带来新的突破希望。


    关键词:ASCO GI/GU;ADC;胰腺癌
首页  上一页  ...  52  53  54  55  56  57  58  59  60  61  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服